Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
David George Kelly currently holds 37,108 shares of Iterum Therapeutics plc (ITRM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David George Kelly has been a net buyer of ITRM stock. They have purchased $62.9K and sold $0 worth of shares.
David George Kelly's most recent insider trade was on Jun 13, 2020, when they sold 11,406 shares at $0.00 per share.
David George Kelly serves as Executive at Iterum Therapeutics plc (ITRM). They have executed 5 insider transactions totaling $62.9K over their tenure at the company.
David George Kelly holds the position of Executive at Iterum Therapeutics plc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 10 years and currently hold a stake valued at $0.
David George Kelly has shown a buying trading pattern, with $62.9K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by David George Kelly was on Nov 30, 2018, when they purchased $62.9K worth of ITRM shares. This transaction involved 10,000 shares at $6.29 per share.
David George Kelly currently owns 37,108 shares of Iterum Therapeutics plc (ITRM), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of David George Kelly's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. David George Kelly has 5 Form 4 filings on record as an insider at Iterum Therapeutics plc.
Set alerts for David George Kelly and 40,000+ other insiders.